CYSTEIN PROTEASE INHIBITOREN

Patent europeic · EP1358183 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1358183
Numer da la dumonda
EP01273876
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
16-11-2001
Publitgà
05-11-2003
Concedì
12-04-2006
Stritgà
30-11-2007
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 407/12 (2006.01)
C07D 409/12 (2006.01)
C07D 309/14 (2006.01)
C07D 307/22 (2006.01)
A61K 31/365 (2006.01)
A61K 31/343 (2006.01)
A61P 19/10 (2006.01)
Prioritad
US 252802 P 17.11.2000
US 252840 P 17.11.2000
Dumonda PCT
PCT/IB2001/002906 16.11.2001
Publicaziun PCT
WO2002/088106 07.11.2002
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2008

    Stritgà, taxa betg pajada

    Published in Swissreg on 01.07.2008

  2. 31-07-2006

    Represchentant inscrit

    Representative
    PA Aldo Römpler, Schützengasse 34, Postfach 229, 9410 Heiden

    Published in +pat+ No 14 in 2006

  3. 13-04-2006

    Concedì

    Published in +pat+ No 7 in 2006

Partidas

Possessur

MEDIVIR AB

Lunastigen 7, 141 44 Huddinge, SE

Represchentant

PA Aldo Römpler

Schützengasse 34 Postfach 229, 9410 Heiden

Inventur

QUIBELL, Martin

Hinton CB1 Cambridgeshire, GB

TAYLOR, Steven

Didcot, Oxon, OX11 7AU, GB

GRABOWSKA, Urszula, Medivir UK Ltd.

Cambridge CB1 9PT, GB

NILSSON, Magnus, Medivir AB

14144 Huddinge, SE

MORISSON, Veronique, Medivir UK Ltd.

Cambridge CB1 9PT, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.